Related references
Note: Only part of the references are listed.Novel Cyclic Endomorphin Analogues with Multiple Modifications and Oligoarginine Vector Exhibit Potent Antinociception with Reduced Opioid-like Side Effects
Yu-zhe Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Development of Multifunctional and Orally Active Cyclic Peptide Agonists of Opioid/Neuropeptide FF Receptors that Produce Potent, Long-Lasting, and Peripherally Restricted Antinociception with Diminished Side Effects
Mengna Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Spinal DN-9, a Peptidic Multifunctional Opioid/Neuropeptide FF Agonist Produced Potent Nontolerance Forming Analgesia With Limited Side Effects
Zilong Wang et al.
JOURNAL OF PAIN (2020)
Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortex
Nobue Kitanaka et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2018)
Systemic administration of the bifunctional opioid/neuropeptide FF receptors agonist BN-9 produced peripheral antinociception in preclinical mouse models of pain
Ning Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Endomorphin-2 analogs with C-terminal esterification produce potent systemic antinociception with reduced tolerance and gastrointestinal side effects
Chang-lin Wang et al.
NEUROPHARMACOLOGY (2017)
Antiallodynic Effects of Endomorphin-1 and Endomorphin-2 in the Spared Nerve Injury Model of Neuropathic Pain in Mice
Chang-lin Wang et al.
ANESTHESIA AND ANALGESIA (2017)
The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse
Charles P. Schaefer et al.
FLUIDS AND BARRIERS OF THE CNS (2017)
MEL-N16: A Series of Novel Endomorphin Analogs with Good Analgesic Activity and a Favorable Side Effect Profile
Xin Liu et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Preclinical Assessment of Inflammatory Pain
Milind M. Muley et al.
CNS NEUROSCIENCE & THERAPEUTICS (2016)
Strategies to Improve Bioavailability and In Vivo Efficacy of the Endogenous Opioid Peptides Endomorphin-1 and Endomorphin-2
Rossella De Marco et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Structure-based discovery of opioid analgesics with reduced side effects
Aashish Manglik et al.
NATURE (2016)
Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities
Wakako Fujita et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Differential antinociceptive effects of intrathecal administration of C-terminal esterified endomorphin-2 analogues in mice
C. L. Wang et al.
EUROPEAN JOURNAL OF PAIN (2014)
Bioavailability of Endomorphins and the Blood-brain Barrier- A Review
Renata Perlikowska et al.
Medicinal Chemistry (2014)
Endomorphin Derivatives with Improved Pharmacological Properties
Pegah Varamini et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Lipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain
Pegah Varamini et al.
FRONTIERS IN PHARMACOLOGY (2013)
Development of Potent μ and δ Opioid Agonists with High Lipophilicity
Yeon Sun Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Development of Opioid Peptide Analogs for Pain Relief
A. Janecka et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Opioid receptor targeting ligands for pain management: a review and update
Mellar P. Davis
EXPERT OPINION ON DRUG DISCOVERY (2010)
Bi- or multifunctional opioid peptide drugs
Peter W. Schiller
LIFE SCIENCES (2010)
Co-administration of δ- and μ-opioid receptor agonists promotes peripheral opioid receptor function
Cicely L. Schramm et al.
PAIN (2010)
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile
N. Dietis et al.
BRITISH JOURNAL OF ANAESTHESIA (2009)
Structure-activity study of endomorphin-2 analogs with C-terminal modifications by NMR spectroscopy and molecular modeling
Chang-lin Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
75 years of opioid research: the exciting but vain quest for the Holy Grail
AD Corbett et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Possible involvement of dynorphin A-(1-17) release via μ1-opioid receptors in spinal antinociception by endomorphin-2
H Mizoguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
CNS drug delivery: Opioid peptides and the blood-brain barrier
KA Witt et al.
AAPS JOURNAL (2006)
Opioid Ligands with mixed mu/delta opioid receptor interactions: An emerging approach to novel analgesics
S Ananthan
AAPS JOURNAL (2006)
Opioid receptors and their ligands
A Janecka et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Share Paper
